Comments on:

FDA official: Agency is committed to timely approval of vaccines

Back to the article » |
An April 10 Manhattan Moment op-ed by Jared Meyer indicated that the Food and Drug Administration has inappropriately delayed access to and approval of a serogroup B meningococcal (or MenB) vaccine in the United States. This assertion is false. FDA is committed both to responding rapidly to public health threats and to approving products for serious medical conditions in a timely manner. While...

To learn more about commenting on and our community guidelines, please see our comments FAQ.